Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Winslow; John W.
Address:
El Granada, CA
No. of patents:
14
Patents:












Patent Number Title Of Patent Date Issued
7935671 Pantropic neurotrophic factors May 3, 2011
Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neurotrophins are als
7528233 Pantropic neurothrophic factors May 5, 2009
Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neurotrophins are als
7144983 Pantropic neurotrophic factors December 5, 2006
Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neurotrophins are als
7067484 AL-1 neurotrophic factor treatments June 27, 2006
The present invention provides nucleic acids encoding AL-1 protein, as well as AL-1 protein produced by recombinant DNA methods. Such AL-1 protein is useful in preparing antibodies and in diagnosing and treating various neuronal disorders.
6610296 Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin August 26, 2003
The present invention provides methods of enhancing cognitive function in mammals by administering intracerebrally a homo-multimeric immunoadhesin molecule that contains the extracellular domain of AL-1, also known as ephrin-A5.
6599717 Invertebrate vascular endothelial growth factor receptor July 29, 2003
Vascular Endothelial Growth Factor Receptor (dmVEGFR) nucleic acids and proteins that have been isolated from Drosophila melanogaster are described. The dmVEGFR nucleic acids and proteins can be used to genetically modify metazoan invertebrate organisms, such as insects and worms, or
6511824 Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use January 28, 2003
Tandem pore domain weak inward rectifying K.sup.+ (TWIK) channel nucleic acids and proteins that have been isolated from Drosophila melanogaster and Leptinotarsa are described. The TWIK channel nucleic acids and proteins can be used to genetically modify metazoan invertebrate organis
6503728 Pantropic neurotrophic factors January 7, 2003
Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neurotrophins are als
6280732 Methods of using an AL-1 neurotrophic factor immunoadhesin August 28, 2001
The present invention provides nucleic acids encoding AL-1 protein, as well as AL-1 protein produced by recombinant DNA methods. Such AL-1 protein is useful in preparing antibodies and in diagnosing and treating various neuronal disorders.
6174701 Neuronal factor January 16, 2001
A novel polypeptide, designated neuronal factor (NF), has been identified by PCR amplification of human genomic DNA. Provided herein is nucleic acid encoding NF useful in diagnostics and in the recombinant preparation of NF. NF is used in the treatment of nerve cells and in diagnostic as
5981480 Pantropic neurotrophic factors November 9, 1999
Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neurotrophins are als
5798448 AL-1 neurotrophic factor antibodies August 25, 1998
The present invention provides nucleic acids encoding AL-1 protein, as well as AL-1 protein produced by recombinant DNA methods. Such AL-1 protein is useful in preparing antibodies and in diagnosing and treating various neuronal disorders.
5759775 Methods for detecting nucleic acids encoding AL--1 neurotrophic factor June 2, 1998
Provided are nucleic acids encoding AL-1 protein, as well as AL-1 protein produced by recombinant DNA methods. Such AL-1 protein is useful in preparing antibodies and in diagnosing and treating various neuronal disorders. The present invention provides methods to preferentially detect
5728803 Pantropic neurotrophic factors March 17, 1998
Pantropic neurotrophic factors which have multiple neurotrophic specificities are provided. The pantropic neurotrophic factors of the present invention are useful in the treatment of neuronal disorders. Nucleic acids and expression vectors encoding the pantropic neurotrophins are als










 
 
  Recently Added Patents
System and method for data storage
Systems and methods for determining user actions
Secure long-range telemetry for implantable medical device
Manufacturing method of random access memory
Delay locked loop circuit and method
Semiconductor memory devices and semiconductor memory systems
Videoconferencing systems with recognition ability
  Randomly Featured Patents
Display screen with graphical user interface
Inflatable mattress with improved border support wall
Pressure roll for a single facer
Production method of optically active diphenylalanine compounds
Variable tensioning system for shear seal valves
Method for plating copper on steel rods
Vehicle front structure
Radiation imaging utilizing data reconstruction to provide transforms which accurately reflect wave propagation characteristics
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
Method of lowering blood pressure by .alpha.-{[arylalkylamino]alkyl}-4-hydroxy-3-(loweralkylsulfinyl)benzenem ethanols